Apogee Therapeutics Inc. Dividend Analysis

APGE

⊜ Compare

Dividend0

No active dividend

This company has no dividend history.

Based on TTM and annual data · Not a buy/sell signal

This company does not pay dividends

No dividend history found in SEC filings.

Does Apogee Therapeutics (APGE) pay a dividend?

Apogee Therapeutics (APGE) has never paid a dividend. Free cash flow is currently negative, so there is no surplus to distribute. All figures are computed from company filings; this is analysis, not investment advice.

Frequently asked

Does Apogee Therapeutics (APGE) pay a dividend?+

No. Apogee Therapeutics (APGE) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.

How does Apogee Therapeutics return cash to shareholders?+

It largely does not. Apogee Therapeutics pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could Apogee Therapeutics afford to pay a dividend?+

Not currently. Apogee Therapeutics's free cash flow is negative at -$244 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Apogee Therapeutics.

More on APGE: Overview · Quality scorecard · DCF valuation · Financials

Dividend guides: Safest high-yield dividend stocks · Best dividend growth stocks · How to tell if a dividend is safe

How the market compares: What percentage of US stocks pay a dividend

SourceDividend analysis computed from the 10-Q filed 10 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 11 Aug 2026. How this is calculated.

Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with APGE

CompareIntrinsic value

ENTXEntera Bio Ltd.

$3.11+1.97%20

ELOXEloxx Pharmaceuticals, Inc.

$12.74-1.39%20

CMPXCompass Therapeutics Inc.

$0.76+1.33%10

SABSSab Biotherapeutics Inc.

$3.18+1.92%19

ARTVArtiva Biotherapeutics Inc.

$4.22+0.48%10

GLUEMonte Rosa Therapeutics, Inc.

$10.82+3.94%10

ALGSAligos Therapeutics Inc.

$5.02+5.68%10

SRRKScholar Rock Holding Corporation

$46.09+4.80%10

Held by ETFs

APGE is in 36 US ETFs. The largest of them, with APGE's weight in each:

Spot a number that looks wrong? Check it in APGE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing APGE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.